Who has invested in Generate Biomedicines?

No investors are named on the public record for Generate Biomedicines yet.

Generate Biomedicines Funding: $750M Raised, IPO (2026)

Generate Biomedicines funding overview

Generate Biomedicines is a Biotech company. Generate Biomedicines has raised $750M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in January 2026. The round record for Generate Biomedicines runs through 2026; nothing later has been disclosed.

Generate Biomedicines at a glance

Total raised: $750M
Latest round: IPO
Latest round date: January 2026
Industry: Biotech

Frequently asked about Generate Biomedicines funding

How much has Generate Biomedicines raised?: Generate Biomedicines has raised $750M in total disclosed funding across the rounds on record.
Who has invested in Generate Biomedicines?: No investors are named on the public record for Generate Biomedicines yet.
What was the latest Generate Biomedicines funding round?: The most recent disclosed round is an IPO, announced in January 2026.
Where is Generate Biomedicines based?: No headquarters location is disclosed for Generate Biomedicines.
What sector does Generate Biomedicines operate in?: Generate Biomedicines is tracked under Biotech, with $750M in disclosed funding.
When did Generate Biomedicines last raise?: The last disclosed Generate Biomedicines round closed in January 2026 at IPO.

We update the Generate Biomedicines record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.

Generate Biomedicines Funding: $750M Raised, IPO (2026)

Generate Biomedicines funding overview

Generate Biomedicines at a glance

Frequently asked about Generate Biomedicines funding

Companies related to Generate Biomedicines (18)

Browse related funding lists (3)